Clear Vision for Healthcare Investing
05.16.2013Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting.
05.15.2013NanoString Technologies Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer.
More News >
Copyright © 2013 Clarus Ventures, LLC - All Rights Reserved